RNA editing in neurological and neurodegenerative disorders
PH Costa Cruz, Y Kawahara - RNA Editing: Methods and Protocols, 2021 - Springer
The brain is one of the organs that are preferentially targeted by adenosine-to-inosine (A-to-
I) RNA editing, a posttranscriptional modification. This chemical modification affects …
I) RNA editing, a posttranscriptional modification. This chemical modification affects …
RNA Editing in Neurological and Neurodegenerative Disorders
PHC Cruz, Y Kawahara - Methods in molecular biology …, 2021 - pubmed.ncbi.nlm.nih.gov
The brain is one of the organs that are preferentially targeted by adenosine-to-inosine (A-to-
I) RNA editing, a posttranscriptional modification. This chemical modification affects …
I) RNA editing, a posttranscriptional modification. This chemical modification affects …
[引用][C] RNA Editing in Neurological and Neurodegenerative Disorders
PHC Cruz, Y Kawahara - Methods in Molecular Biology, 2020 - cir.nii.ac.jp
RNA Editing in Neurological and Neurodegenerative Disorders | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
RNA Editing in Neurological and Neurodegenerative Disorders
PHC Cruz, Y Kawahara - RNA Editing - Springer
The brain is one of the organs that are preferentially targeted by adenosine-to-inosine (A-to-
I) RNA editing, a posttranscriptional modification. This chemical modification affects …
I) RNA editing, a posttranscriptional modification. This chemical modification affects …
RNA Editing in Neurological and Neurodegenerative Disorders.
CC PH, Y Kawahara - Methods in Molecular Biology (Clifton, NJ), 2021 - europepmc.org
The brain is one of the organs that are preferentially targeted by adenosine-to-inosine (A-to-
I) RNA editing, a posttranscriptional modification. This chemical modification affects …
I) RNA editing, a posttranscriptional modification. This chemical modification affects …